<DOC>
	<DOCNO>NCT02471677</DOCNO>
	<brief_summary>The purpose randomize control trial ( RCT ) compare single injection corifollitropin-alfa versus daily injection follitropin beta regard number oocyte retrieve , hormonal profile follicle development patient high response undergo ovarian stimulation vitro fertilization treatment use gonadotropin-releasing hormone ( GnRH ) antagonist protocol combine GnRH agonist trigger cryopreservation embryo .</brief_summary>
	<brief_title>Corifollitropin Alfa Versus Follitropin Beta High Responders</brief_title>
	<detailed_description>Corifollitropin alfa , novel fusion protein lack luteinizing hormone ( LH ) activity , long elimination half-life extend time peak level recombinant follicle stimulate hormone ( rFSH ) . A single injection corifollitropin alfa may replace seven daily injection follitropin beta first week ovarian stimulation , reduce patient discomfort . The purpose RCT compare single injection corifollitropin-alfa versus daily injection follitropin beta regard number oocyte retrieve , well hormonal profile follicle development patient high response undergo ovarian stimulation IVF use GnRH antagonist protocol . In addition , incidence unexpected ovarian hyperstimulation syndrome ( OHSS ) evaluate , although anticipate GnRH agonist trigger eliminate occurrence syndrome .</detailed_description>
	<mesh_term>Infertility</mesh_term>
	<mesh_term>Follicle Stimulating Hormone</mesh_term>
	<criteria>Age : 1840 year Polycystic ovary ( PCO ) polycystic ovary syndrome ( PCOS ) endometriotic cyst Patients poor response Patients use human chorionic gonadotropin ( hCG ) trigger final oocyte maturation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>June 2015</verification_date>
	<keyword>Ovarian stimulation</keyword>
	<keyword>corifollitropin alfa</keyword>
	<keyword>GnRH antagonist protocol</keyword>
	<keyword>high responder</keyword>
	<keyword>follitropin beta</keyword>
</DOC>